eqloprtntyh8r's Profile
eqloprtntyh8r's Posts
Mark Cuban just retweeted this article:
https://twitter.com/mcuban/status/348846487523962880
Interesting that such a high profile name, and his 1.7 million followers, now have heard of MNKD because of some groups dastardly training practices.
1 step backwards, two steps forward?
Thank you for the welcome!
Both links were great, thanks!
I just wanted to post the response I had in the comments section of the article that I had to to Adam.
He repeatedly kept asking about what evidence anyone had to refute his "clinical significant" findings.
I don't expect a response on his article, thus wanted to get it out to show Adam:
1. Misrepresented Data
2. Does not respond to valid questions / comments on his articles
Great link library, great source of information!
Adam F from "The Street" redefines the term "clinically significant" for FEV1 reduction in his article titled:
"MannKind's Mysterious Lung-Safety Study Is Open But Shhh...Don't Talk About It"
http://www.thestreet.com/story/11897731/2/mannkinds-mysterious-lung-safety-study-is-open-but-shhhdont-talk-about-it.html
Adam makes the statement:
"The chart above is reprinted from the lung-safety study results published in Diabetes, Obesity & Metabolism. It shows a statistically significant, 34 ml relative decrease in forced vital capacity for Afrezza compared to usual care after 24 months."
The Problem:
Adam's definition of "clinically significant" does not:is not aligned with:
1. Definition of "statistically significant" within this trial:
Non-inferiority = annualized change is no greater than 50 mL/year.
The 34 and 37 mL decrease was below this number, thus the P value being less than 0.05.
2. Definition of "statistically significant" from the American Thoracic Society:
The American Thoracic Society (ATS)
recommends a 15% year-to-year FEV1
decline for clinical significance.
With a baseline of 3.24 and 3.29, the 34 mL reduction equates to:
10%
He defends this term vigorously in the comments section, and is a blatant misrepresentation of facts to mislead investors, as I'm fairly confident Adam understands statistics, or I hope so, as his mantra is "Data Are".
Well, "Data Are" was misrepresented.
I'm mad as hell, and I'm not going to take it any more!